Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert Paul Hasserjian, M.D.

Co-Author

This page shows the publications co-authored by Robert Hasserjian and Damodaran Narayanan.
Connection Strength

0.481
  1. TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML. Blood Adv. 2022 Jan 24.
    View in: PubMed
    Score: 0.246
  2. Effect of DNMT3A variant allele frequency and double mutation on clinicopathologic features of patients with de novo AML. Blood Adv. 2021 06 08; 5(11):2539-2549.
    View in: PubMed
    Score: 0.235
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.